Liraglutide TFA
Liraglutide (TFA) is an agonist of the glucagon-like peptide 1 receptor (GLP-1) . It activates GLP-1, leading to insulin secretion when glucose levels are elevated. Additionally, Liraglutide (TFA) reduces glucagon secretion in a glucose-dependent manner. This compound is utilized in research related to type 2 diabetes.
Product Specifications
Field of Research
Immunology & Inflammation; Pharmacology & Drug Discovery, Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog